Wellington Shields Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
3,578
+101
+3% +$34.6K 0.16% 104
2026
Q1
$1.22M Sell
3,477
-8
-0.2% -$2.85K 0.18% 93
2025
Q4
$1.14M Buy
3,485
+2
+0.1% +$634 0.17% 102
2025
Q3
$983K Sell
3,483
-99
-3% -$28.7K 0.15% 114
2025
Q2
$1M Sell
3,582
-224
-6% -$63.5K 0.17% 109
2025
Q1
$1.19M Sell
3,806
-233,674
-98% -$69M 0.22% 90
2024
Q4
$991K Buy
237,480
+233,679
+6,148% +$69.3M 0.18% 98
2024
Q3
$1.22M Buy
3,801
+2
+0.1% +$654 0.21% 95
2024
Q2
$1.19M Buy
3,799
+102
+3% +$30K 0.22% 94
2024
Q1
$1.05M Sell
3,697
-124
-3% -$36.3K 0.2% 102
2023
Q4
$1.1M Sell
3,821
-49
-1% -$13.4K 0.14% 100
2023
Q3
$1.04M Buy
3,870
+2
+0.1% +$499 0.14% 98
2023
Q2
$859K Sell
3,868
-299
-7% -$69.4K 0.1% 111
2023
Q1
$1.01M Sell
4,167
-97
-2% -$23.8K 0.12% 99
2022
Q4
$1.12M Buy
4,264
+1
+0% +$268 0.14% 92
2022
Q3
$961K Sell
4,263
-98
-2% -$23.8K 0.23% 101
2022
Q2
$1.06M Sell
4,361
-86,523
-95% -$21.2M 0.13% 94
2022
Q1
$1.14M Buy
90,884
+84,728
+1,376% +$19.5M 0.12% 107
2021
Q4
$1.39M Buy
+6,156
New +$1.3M 0.18% 117
2021
Q3
Sell
-7,300
Closed -$1.78M 263
2021
Q2
$1.78M Sell
7,300
-148,586
-95% -$36.6M 0.22% 97
2021
Q1
$38.8M Buy
155,886
+148,636
+2,050% +$35.5M 3.68% 4
2020
Q4
$1.67M Buy
7,250
+6,250
+625% +$1.44M 0.22% 88
2020
Q3
$254K Sell
1,000
-6
-0.6% -$1.49K 0.04% 204
2020
Q2
$237K Buy
1,006
+6
+0.6% +$1.37K 0.04% 216
2020
Q1
$203K Hold
1,000
0.04% 218
2019
Q4
$241K Sell
1,000
-100
-9% -$22K 0.04% 235
2019
Q3
$213K Hold
1,100
0.03% 248
2019
Q2
$203K Buy
+1,100
New +$197K 0.03% 264
2018
Q4
Sell
-975
Closed -$202K 274
2018
Q3
$202K Buy
+975
New +$192K 0.03% 295
2018
Q2
Sell
-1,975
Closed -$337K 309
2018
Q1
$337K Hold
1,975
0.05% 247
2017
Q4
$343K Hold
1,975
0.05% 257
2017
Q3
$368K Sell
1,975
-400
-17% -$70.9K 0.06% 236
2017
Q2
$409K Hold
2,375
0.07% 233
2017
Q1
$390K Hold
2,375
0.06% 228
2016
Q4
$347K Hold
2,375
0.06% 235
2016
Q3
$396K Hold
2,375
0.07% 235
2016
Q2
$361K Sell
2,375
-3,000
-56% -$466K 0.06% 239
2016
Q1
$806K Sell
5,375
-4,400
-45% -$654K 0.14% 137
2015
Q4
$1.59M Sell
9,775
-2,000
-17% -$314K 0.27% 74
2015
Q3
$1.63M Sell
11,775
-5,450
-32% -$859K 0.28% 68
2015
Q2
$2.64M Sell
17,225
-625
-4% -$100K 0.4% 50
2015
Q1
$2.85M Sell
17,850
-100
-0.6% -$15.7K 0.43% 50
2014
Q4
$2.86M Buy
17,950
+1,400
+8% +$218K 0.45% 44
2014
Q3
$2.33M Sell
16,550
-400
-2% -$52.2K 0.39% 51
2014
Q2
$2.01M Sell
16,950
-750
-4% -$86.8K 0.31% 62
2014
Q1
$2.18M Hold
17,700
0.37% 47
2013
Q4
$2.02M Hold
17,700
0.36% 51
2013
Q3
$1.98M Sell
17,700
-400
-2% -$43.4K 0.38% 49
2013
Q2
$1.79M Buy
+18,100
New +$1.88M 0.32% 59

Other funds holding AMGN

Wellington Shields Capital Management's AMGN Position: Q2 2026 in Review

Wellington Shields Capital Management increased its Amgen (AMGN) stake by 2.9% in Q2 2026, buying an estimated $34.6K and bringing the position to 3,578 shares worth $1.3M. The position accounts for 0.16% of the portfolio, ranked #104.

Wellington Shields Capital Management first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $38.8M in Q1 2021. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wellington Shields Capital Management held 3,578 shares of Amgen worth $1.3M as of Q2 2026.
  • Wellington Shields Capital Management bought 101 Amgen shares in Q2 2026, an estimated $34.6K.
  • Amgen made up 0.16% of Wellington Shields Capital Management's portfolio in Q2 2026, its #104 holding.
  • Wellington Shields Capital Management first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • Wellington Shields Capital Management's Amgen position peaked at $38.8M in Q1 2021.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.